Matrix metalloproteinase expression after human cardioembolic stroke -: Temporal profile and relation to neurological impairment

被引:287
作者
Montaner, J
Alvarez-Sabín, J
Molina, C
Anglés, A
Abilleira, S
Arenillas, J
González, MA
Monasterio, J
机构
[1] Hosp Gen Valle Hebron, Cerebrovasc Unit, Barcelona 08035, Spain
[2] Hosp Gen Valle Hebron, Hemostasia Res Unit, Barcelona 08035, Spain
关键词
cerebral ischemia; matrix metalloproteinases; stroke; cardioembolic;
D O I
10.1161/01.STR.32.8.1759
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Uncontrolled expression of matrix metalloproteinases (MMPs) can result in tissue injury and inflammation. In animal models of cerebral ischemia, the expression of MMP-2 and MMP-9 was significantly increased. However, their role in human stroke in vivo remains unknown. Therefore, we sought to determine the temporal profile of MMP expression in patients with acute ischemic stroke and to investigate its relationship to stroke severity, location of arterial occlusion, and total infarct volume. Methods-Serial MMP-2 and MMP-9 determinations were made in 39 patients with cardioembolic strokes that involved the middle cerebral artery territory by means of enzyme-linked immunosorbent assay. Blood samples, transcranial Doppler recordings, and National Institutes of Health Stroke Scale (NIHSS) scores were obtained at baseline and at 12, 24, and 48 hours after stroke onset. Infarct volume was measured with CT scanning at 48 hours. Results-No correlation was found between MMP-2 and NIHSS score at any time point, although a close relation appeared between mean MMP-9 and final NIHSS score (r=0.486, P=0.002). MMP-9 value was the only factor associated with the final NIHSS score in the multiple logistic regression model (OR 4.54, 95% Cl 1.5 to 13.75). A cut-point of MMP-9 142.18 ng/mL had a positive predictive value of 94.4% to assess a patient's NIHSS (<8 or greater than or equal to8) by the end of the study. Final MMP-2 and MMP-9 levels were significantly lower when recanalization occurred (528 +/- 144.3 versus 681.4 +/- 239.2 ng/mL, P=0.031 for MMP-2; 110.2 +/- 100.9 versus 244.8 +/- 130 ng/mL, P=0.004 for MMP-9). A positive correlation was found between mean MMP-9 and infarct volume (r=0.385, P=0.022). Conclusions-MMPs are involved in the acute phase of human ischemic stroke. MMP-9 levels are associated with neurological deficit, middle cerebral artery occlusion, and infarct volume.
引用
收藏
页码:1759 / 1766
页数:8
相关论文
共 28 条
  • [1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [2] Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
    Anthony, DC
    Ferguson, B
    Matyzak, MK
    Miller, KM
    Esiri, MM
    Perry, VH
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (05) : 406 - 415
  • [3] Role for matrix metalloproteinase 9 after focal cerebral ischemia, effects of gene knockout and enzyme inhibition with BB-94
    Asahi, M
    Asahi, K
    Jung, JC
    del Zoppo, GJ
    Fini, ME
    Lo, EH
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (12) : 1681 - 1689
  • [4] URGENT THERAPY FOR STROKE .1. PILOT-STUDY OF TISSUE PLASMINOGEN-ACTIVATOR ADMINISTERED WITHIN 90 MINUTES
    BROTT, TG
    HALEY, EC
    LEVY, DE
    BARSAN, W
    BRODERICK, J
    SHEPPARD, GL
    SPILKER, J
    KONGABLE, GL
    MASSEY, S
    REED, R
    MARLER, JR
    [J]. STROKE, 1992, 23 (05) : 632 - 640
  • [5] Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia
    Clark, AW
    Krekoski, CA
    Bou, SS
    Chapman, KR
    Edwards, DR
    [J]. NEUROSCIENCE LETTERS, 1997, 238 (1-2) : 53 - 56
  • [6] Progression in acute stroke - Value of the initial NIH Stroke Scale score on patient stratification in future trials
    DeGraba, TJ
    Hallenbeck, JM
    Pettigrew, KD
    Dutka, AJ
    Kelly, BJ
    [J]. STROKE, 1999, 30 (06) : 1208 - 1212
  • [7] Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion
    Fujimura, M
    Gasche, Y
    Morita-Fujimura, Y
    Massengale, J
    Kawase, M
    Chan, PH
    [J]. BRAIN RESEARCH, 1999, 842 (01) : 92 - 100
  • [8] Fujioka KA., 1992, TRANSCRANIAL DOPPLER, P9
  • [9] GARCIA JH, 1994, AM J PATHOL, V144, P188
  • [10] Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: A possible role in blood-brain barrier dysfunction
    Gasche, Y
    Fujimura, M
    Morita-Fujimura, Y
    Copin, JC
    Kawase, M
    Massengale, J
    Chan, PH
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (09) : 1020 - 1028